Linden Thomas Advisory Services, LLC Vanda Pharmaceuticals Inc. Transaction History
Linden Thomas Advisory Services, LLC
- $908 Billion
- Q2 2025
A detailed history of Linden Thomas Advisory Services, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 11,224 shares of VNDA stock, worth $48,375. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,224
Previous 10,649
5.4%
Holding current value
$48,375
Previous $48.9 Million
8.38%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
44MCall Options Held
49.4KPut Options Held
562K-
Black Rock Inc. New York, NY8.14MShares$35.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$15.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.57MShares$15.4 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$11.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.1 Million0.7% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...